These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. [Cytomegalovirus infection and coronary sclerosis after heart transplantation]. Loebe M; Schüler S; Spiegelsberger S; Warnecke H; Fleck E; Hetzer R Dtsch Med Wochenschr; 1990 Aug; 115(34):1266-9. PubMed ID: 2167829 [TBL] [Abstract][Full Text] [Related]
24. Incidence of obliterative bronchiolitis after heart-lung transplantation in children. Whitehead B; Rees P; Sorensen K; Bull C; Higenbottam TW; Wallwork J; Fabre J; Elliott M; de Leval M J Heart Lung Transplant; 1993; 12(6 Pt 1):903-8. PubMed ID: 8312313 [TBL] [Abstract][Full Text] [Related]
25. Paramyxovirus infection in lung transplant recipients. Wendt CH; Fox JM; Hertz MI J Heart Lung Transplant; 1995; 14(3):479-85. PubMed ID: 7654733 [TBL] [Abstract][Full Text] [Related]
26. Comparison of serology assays and polymerase chain reaction for the monitoring of active cytomegalovirus infection in renal transplant recipients. Naumnik B; Małyszko J; Chyczewski L; Kovalchuk O; Małyszko J; Myśliwiec M Transplant Proc; 2007 Nov; 39(9):2748-50. PubMed ID: 18021976 [TBL] [Abstract][Full Text] [Related]
27. Are heart-lung transplant recipients protected from developing bronchiolitis obliterans syndrome? Moffatt-Bruce SD; Karamichalis J; Robbins RC; Whyte RI; Theodore J; Reitz BA Ann Thorac Surg; 2006 Jan; 81(1):286-91; discussion 291. PubMed ID: 16368382 [TBL] [Abstract][Full Text] [Related]
28. Long-term outcomes of cytomegalovirus infection and disease after lung or heart-lung transplantation with a delayed ganciclovir regimen. Thomas LD; Milstone AP; Miller GG; Loyd JE; Stephen Dummer J Clin Transplant; 2009; 23(4):476-83. PubMed ID: 19453645 [TBL] [Abstract][Full Text] [Related]
29. Long-term results of combined heart-lung transplantation: the Stanford experience. Sarris GE; Smith JA; Shumway NE; Stinson EB; Oyer PE; Robbins RC; Billingham ME; Theodore J; Moore KA; Reitz BA J Heart Lung Transplant; 1994; 13(6):940-9. PubMed ID: 7865527 [TBL] [Abstract][Full Text] [Related]
32. Immune monitoring of anti cytomegalovirus antibodies and risk of cytomegalovirus disease in heart transplantation. Sarmiento E; Lanio N; Gallego A; Rodriguez-Molina J; Navarro J; Fernandez-Yañez J; Palomo J; Rodríguez-Hernández C; Ruiz M; Alonso R; Fernandez-Cruz E; Carbone J Int Immunopharmacol; 2009 Jun; 9(6):649-52. PubMed ID: 18940269 [TBL] [Abstract][Full Text] [Related]
33. Bronchiolitis obliterans syndrome and early human cytomegalovirus DNAaemia dynamics after lung transplantation. Westall GP; Michaelides A; Williams TJ; Snell GI; Kotsimbos TC Transplantation; 2003 Jun; 75(12):2064-8. PubMed ID: 12829913 [TBL] [Abstract][Full Text] [Related]
34. Association of cytomegalovirus infection with human leukocyte antigen genotypes in recipients after allogeneic liver transplantation. Fan J; Meng XQ; Yang MF; Zhou L; Chen XM; Hu MJ; Fan WW; Ma WH; Li LJ Hepatobiliary Pancreat Dis Int; 2006 Feb; 5(1):34-8. PubMed ID: 16481279 [TBL] [Abstract][Full Text] [Related]
35. Use of cytomegalovirus (CMV) hyperimmune globulin for prevention of CMV disease in CMV-seropositive lung transplant recipients. Zamora MR; Fullerton DA; Campbell DN; Leone S; Diercks MJ; Fisher JH; Badesch DB; Grover FL Transplant Proc; 1994 Oct; 26(5 Suppl 1):49-51. PubMed ID: 7940974 [TBL] [Abstract][Full Text] [Related]
36. Who waits longest for heart and lung transplantation? Sharples L; Belcher C; Dennis C; Higenbottam T; Wallwork J J Heart Lung Transplant; 1994; 13(2):282-91. PubMed ID: 8031813 [TBL] [Abstract][Full Text] [Related]
37. Decreased levels of serum immunoglobulins as a risk factor for infection after heart transplantation. Sarmiento E; Rodríguez-Molina J; Muñoz P; Fernández-Yánez J; Palomo J; Fogueda M; Fernández-Cruz E; Bouza E; Carbone J Transplant Proc; 2005 Nov; 37(9):4046-9. PubMed ID: 16386623 [TBL] [Abstract][Full Text] [Related]
38. Pulmonary infiltrates after heart-lung transplantation: evaluation by serial transbronchial biopsies. Starnes VA; Theodore J; Oyer PE; Stinson EB; Moreno-Cabral CE; Sibley R; Barry G; Shumway NE J Thorac Cardiovasc Surg; 1989 Nov; 98(5 Pt 2):945-50. PubMed ID: 2554070 [TBL] [Abstract][Full Text] [Related]
39. The natural history of obliterative bronchiolitis and occlusive vascular disease of patients following heart-lung transplantation. Scott JP; Higenbottam TW; Clelland C; Hutter JA; Stewart S; Otulana BA; Wallwork J Transplant Proc; 1989 Feb; 21(1 Pt 3):2592-3. PubMed ID: 2539680 [No Abstract] [Full Text] [Related]
40. Causes of death in lung transplant recipients. Chaparro C; Maurer JR; Chamberlain D; De Hoyos A; Winton T; Westney G; Kesten S J Heart Lung Transplant; 1994; 13(5):758-66. PubMed ID: 7803415 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]